EU recommends suspending hundreds of drugs tested by Indian firm
LONDON (Reuters) - Europe's medicines regulator has recommended the suspension of more than 300 generic drug approvals and drug applications due to "unreliable" tests conducted by Indian contract research firm Micro Therapeutic Research Labs.
No comments:
Post a Comment